We are racing to put algorithms in charge of high-stakes clinical workflows, but this week’s developments show that the gap between raw computational capability and real-world safety is wider than we want to admit.
🔹 AI Diagnoses Brain Tumors in Twelve Minutes — A new computational pathology model diagnoses complex brain tumors in 12 minutes rather than weeks.
My take: This is a massive win for surgical oncology. When I was building Yesil Health, I saw how much latency kills clinical utility; getting these answers while the patient is still on the table changes everything.
🔹 NHS Bets Big on Microsoft Copilot — A massive £120 million bet on administrative AI will test whether digital tools can rescue overburdened clinicians from paperwork.
My take: Giving half a million staff members Copilot is a bold experiment, but if the underlying clinical data is messy, we are just automating bad habits at scale.
🔹 AI models mistake Pokemon for real prescription drugs — A new study reveals that major AI models routinely prescribe dosing instructions for fictional Pokemon characters.
My take: This is a hilarious but terrifying reminder of why LLMs cannot be trusted blindly. If a model hallucinates a dosing schedule for a Pikachu, it cannot be trusted with actual patient charts.
🔹 AI-Designed Universal Vaccine Passes Human Trial — A new needle-free vaccine targeting shared viral structures could finally end our endless cycle of booster reformulations.
My take: Moving from reactive variant chasing to generative, universal design is the exact paradigm shift we need to prevent the next pandemic.
🔹 Rapid Identification of Colistin-Resistant E. cloacae — A new machine learning workflow cuts the detection time for superbugs down to 60 minutes.
My take: Waiting days for drug-susceptibility testing in the ICU is a clinical nightmare. Bringing this down to an hour will save lives and preserve our last-line antibiotics.
